Vulnerability · CVE-2026-2251
Improper limitation of a pathname to a restricted directory (Path Traversal) vulnerability in Xerox FreeFlow Core allows unauthorized path traversal leading to RCE.
Published Feb 27, 2026 · catalog updated Jun 17, 2026 · freeflow core
Check if you run it
No confirmed exploitation is on record for CVE-2026-2251. EPSS is 0.40%. Act only if a listed version of freeflow core is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Critical9.8
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.40%
- Remediation
- Version ranges on file
- Affected products
- cpe xerox/freeflow core · stated freeflow core
Improper limitation of a pathname to a restricted directory (Path Traversal) vulnerability in Xerox FreeFlow Core allows unauthorized path traversal leading to RCE. This issue affects Xerox FreeFlow Core versions up to and including 8.0.7. Please consider upgrading to FreeFlow Core version 8.1.0 via the software available on - https://www.support.xerox.com/en-us/product/core/downloads https://www.support.xerox.com/en-us/product/core/downloads
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe xerox/freeflow coreversion unspecified
- stated freeflow core<= 8.0.7
How to fix CVE-2026-2251
Recommended remediation
Affected version ranges suggest a fixed boundary. Verify against the vendor advisory for your release.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-2251. EPSS is 0.40%. Act only if a listed version of freeflow core is installed.
Which versions are affected?
Compare what you have installed with freeflow core <= 8.0.7. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-22: Path Traversal. EPSS 0.40%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Feb 27, 2026 · NIST NVD
Detected
Improper limitation of a pathname to a restricted directory (Path Traversal) vulnerability in Xerox FreeFlow Core allows unauthorized path traversal leading to RCE. This issue affects Xerox FreeFlow Core versions up to and including 8.0.7. Please consider upgrading to FreeFlow Core version 8.1.0 via the software available on - https://www.support.xerox.com/en-us/product/core/downloads https://www.
Jun 17, 2026 · NIST NVD
Updated
Improper limitation of a pathname to a restricted directory (Path Traversal) vulnerability in Xerox FreeFlow Core allows unauthorized path traversal leading to RCE. This issue affects Xerox FreeFlow Core versions up to and including 8.0.7. Please consider upgrading to FreeFlow Core version 8.1.0 via the software available on - https://www.support.xerox.com/en-us/product/core/downloads https://www.
Sources
- CVE.orgVulnerability recordCVE-2026-2251
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-2251
30-day exploitation probability 0.4%
first.org - NIST NVDVulnerability recordCVE-2026-2251
Improper limitation of a pathname to a restricted directory (Path Traversal) vulnerability in Xerox FreeFlow Core allows unauthorized path traversal leading to RCE. This issue affects Xerox FreeFlow Core versions up to and including 8.0.7. Please consider upgrading to Fre
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.